Report

Global Smoking Cessation Aids Market Size study, by Product (Nicotine Replacement Therapy, Drugs, Electronic Cigarettes, Others) by End User (Hospital Pharmacies, Online Channel, Retail Pharmacies, Others) and Regional Forecasts 2021-2027

  • Publish Date: Mar,2022
  • Report ID: QI037
  • Page : 250
  • Report Type : PDF (Email)
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Smoking Cessation Aids Market, by Region, 2019-2027 (USD Billion)
1.2.2. Smoking Cessation Aids Market, by Product, 2019-2027 (USD Billion)
1.2.3. Smoking Cessation Aids Market, by End User, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Smoking Cessation Aids Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Smoking Cessation Aids Market Dynamics
3.1. Smoking Cessation Aids Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Massive smoking population around the world
3.1.1.2. Anti-smoking campaigns by government & NGOs
3.1.2. Market Challenges
3.1.2.1. High development cost of de-addiction therapies and products
3.1.3. Market Opportunities
3.1.3.1. Rising awareness about harms of smoking tobacco
Chapter 4. Global Smoking Cessation Aids Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Smoking Cessation Aids Market, by Product
5.1. Market Snapshot
5.2. Global Smoking Cessation Aids Market by Product, Performance - Potential Analysis
5.3. Global Smoking Cessation Aids Market Estimates & Forecasts by Product 2018-2027 (USD Billion)
5.4. Smoking Cessation Aids Market, Sub Segment Analysis
5.4.1. Nicotine Replacement Therapy
5.4.2. Drugs
5.4.3. Electronic cigarettes
5.4.4. Others
Chapter 6. Global Smoking Cessation Aids Market, by End User
6.1. Market Snapshot
6.2. Global Smoking Cessation Aids Market by End User, Performance - Potential Analysis
6.3. Global Smoking Cessation Aids Market Estimates & Forecasts by End User 2018-2027 (USD Billion)
6.4. Smoking Cessation Aids Market, Sub Segment Analysis
6.4.1. Hospital Pharmacies
6.4.2. Online Channel
6.4.3. Retail Pharmacies
6.4.4. Others
Chapter 7. Global Smoking Cessation Aids Market, Regional Analysis
7.1. Smoking Cessation Aids Market, Regional Market Snapshot
7.2. North America Smoking Cessation Aids Market
7.2.1. U.S. Smoking Cessation Aids Market
7.2.1.1. Product breakdown estimates & forecasts, 2018-2027
7.2.1.2. End User breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Smoking Cessation Aids Market
7.3. Europe Smoking Cessation Aids Market Snapshot
7.3.1. U.K. Smoking Cessation Aids Market
7.3.2. Germany Smoking Cessation Aids Market
7.3.3. France Smoking Cessation Aids Market
7.3.4. Spain Smoking Cessation Aids Market
7.3.5. Italy Smoking Cessation Aids Market
7.3.6. Rest of Europe Smoking Cessation Aids Market
7.4. Asia-Pacific Smoking Cessation Aids Market Snapshot
7.4.1. China Smoking Cessation Aids Market
7.4.2. India Smoking Cessation Aids Market
7.4.3. Japan Smoking Cessation Aids Market
7.4.4. Australia Smoking Cessation Aids Market
7.4.5. South Korea Smoking Cessation Aids Market
7.4.6. Rest of Asia Pacific Smoking Cessation Aids Market
7.5. Latin America Smoking Cessation Aids Market Snapshot
7.5.1. Brazil Smoking Cessation Aids Market
7.5.2. Mexico Smoking Cessation Aids Market
7.6. Rest of The World Smoking Cessation Aids Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. NJOY
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Pfizer Inc.
8.2.3. GlaxoSmithKline Plc
8.2.4. F. Hoffmann-La Roche AG
8.2.5. Novartis AG
8.2.6. Johnson and Johnson
8.2.7. Bayer AG
8.2.8. Cipla Ltd.
8.2.9. Takeda Pharmaceutical Ltd.
8.2.10. Dr. Reddy's Laboratories
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption